Efficacy and mechanism of Yudanrongxin pills in acute myocardial infarction
10.3969/j.issn.1005-1678.2016.06.43
- VernacularTitle:玉丹荣心丸治疗急性心肌梗死的疗效及可能机制
- Author:
Jingyao LI
;
Jijia WANG
;
Hua XU
;
Xianghong SONG
;
Yue ZHAO
- Publication Type:Journal Article
- Keywords:
Yudanrongxin pills;
myocardial infarction;
inflammatory factor;
myocardial injury;
cardiac function
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(6):145-147
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical effect and mechanism of Yudanrongxin pills in the treatment of patients with acute myocardial infarction ( AMI) .Methods 86 cases of AMI in our hospital from February 2014 to February 2015 were selected and divided into the observation group and the control group, with 43 cases in each group.The patients in the control group were treated with conventional therapy, while patients in observation group were treated with Yudanrongxin pills on the basis of the control group.The related inflammation factors, indicators of myocardial injury and heart function index were compared between two groups before and after treatment.Results Compared with before treatment, in both two groups after treatment, the serum inflammatory factors including high-sensitivity C-reactive protein(hs-CRP), IL-6,soluble vascular cellular adhesion molecule-1 (sVCAM-1), TNF-αand P-selectin decreased, the myocardial injury criterion including creatine kinase-MB (CK-MB), lactate dehydrogenase (LD), myocardial troponin I (cTnI) and myoglobin (Mb) decreased,the cardiac function indexes of left ventricular end systolic volume (LVESV) and left ventricular end diastolic volume (LVEDV) decreased and left ventricular ejection fraction (LVEF) increased (P<0.05).Compared with control group, the hs-CRP,IL-6,sVCAM-1,TNF-α,P-selectin,CK-MB,LD,cTnI and Mb in observation group were lower(P<0.05).The degree of improvement at cardiac function was better than that in control group (P<0.05).Conclusion Yudanrongxin pills could better improve cardiac function in treatment with AMI, its role was relative to inhibition of inflammatory factors and myocardial protection against injury.
